Prothena
Price & Volume
Stats
See moreOpen | $10.42 |
Previous Close | $10.30 |
Day Range | $10.21-$10.43 |
52W Range | $4.32-$18.88 |
Market Cap | $554.4M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $10.3M |
Revenue Growth (YoY) | -96.7% |
Gross Profit (12 Mos) | -$181.8M |
Diluted EPS | -$5.62 |
News
See moreYahoo Finance • 8 days ago
Bristol Myers Alzheimer's Drug Earns FDA Fast Track
Yahoo Finance • 9 days ago
Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease
Yahoo Finance • 2 months ago
Prothena’s SWOT analysis: stock outlook shifts amid pipeline changes
Yahoo Finance • 2 months ago
Novo Nordisk boosts Prothena on plans for amyloidosis therapy
About
CEO | Dr. Gene G. Kinney Ph.D. |
CFO | Mr. Tran B. Nguyen M.B.A. |
Address | 77 Sir John Rogerson?s Quay, Dublin, Ireland, D02 VK60 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 163 |
